Location: Stockholm, Sweden
CIK: 0001599882 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: Apr 19, 2016
Total Value: $504M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Alexion Pharmaceuticals Inc | 121,000 | $16.85M | 3.3% | $160.08 | — | COM | 015351109 |
| GILD | Gilead Sciences Inc | 180,000 | $16.54M | 3.3% | $64.82 | -2.1% | COM | 375558103 |
| BMRN | BioMarin Pharmaceutical Inc | 190,000 | $15.67M | 3.1% | $86.90 | -6.4% | COM | 09061G101 |
| PFE | Pfizer Inc | 475,000 | $14.08M | 2.8% | $20.45 | -8.6% | COM | 717081103 |
| LLY | Eli Lilly & Co | 195,000 | $14.04M | 2.8% | $58.70 | +9.0% | COM | 532457108 |
| ALKS | Alkermes Plc | 405,000 | $13.85M | 2.7% | $45.76 | -13.7% | SHS | G01767105 |
| INCY | Incyte Corp Ltd | 170,000 | $12.32M | 2.4% | $71.96 | +3.6% | COM | 45337C102 |
| — | Celgene Corp | 120,000 | $12.01M | 2.4% | $111.51 | — | COM | 151020104 |
| — | Abiomed Inc | 125,000 | $11.85M | 2.4% | $74.57 | — | COM | 003654100 |
| — | Allergan Plc | 42,000 | $11.26M | 2.2% | $302.63 | — | SHS | G0177J108 |
| CVS | CVS Health Corp | 105,000 | $10.89M | 2.2% | $67.72 | +6.9% | COM | 126650100 |
| MDT | Medtronic Plc | 137,000 | $10.28M | 2.0% | $58.05 | +1.5% | SHS | G5960L103 |
| — | St Jude Medical Inc | 180,000 | $9.9M | 2.0% | $64.52 | — | COM | 790849103 |
| BIIB | Biogen Inc | 38,000 | $9.892M | 2.0% | $264.15 | 0.0% | COM | 09062X103 |
| ZBH | Zimmer Biomet Hgs Inc | 91,000 | $9.703M | 1.9% | $91.33 | -2.3% | COM | 98956P102 |
| — | Cigna Corp | 69,000 | $9.47M | 1.9% | $135.02 | — | COM | 125509109 |
| BMY | Bristol Myers Squibb Co | 142,000 | $9.071M | 1.8% | $39.46 | +13.5% | COM | 110122108 |
| — | Laboratory Corp of America Hgs | 75,000 | $8.785M | 1.7% | $121.84 | — | COM | 50540R409 |
| CNC | Centene Corp | 141,712 | $8.725M | 1.7% | $30.22 | -1.2% | COM | 15135B101 |
| — | Medivation Inc | 187,000 | $8.598M | 1.7% | $53.83 | — | COM | 58501N101 |
| — | Walgreens Boots Alliance Inc | 100,000 | $8.424M | 1.7% | $85.15 | — | COM | 931427108 |
| HCA | HCA Holdings Inc | 104,000 | $8.117M | 1.6% | $70.94 | -8.5% | COM | 40412C101 |
| ALNY | Alnylam Pharmaceuticals Inc | 125,000 | $7.846M | 1.6% | $82.00 | -18.9% | COM | 02043Q107 |
| PRGO | Perrigo Co Plc | 61,000 | $7.804M | 1.5% | $165.12 | -17.2% | SHS | G97822103 |
| UNH | United Health Group Inc | 60,000 | $7.734M | 1.5% | $89.16 | +13.2% | COM | 91324P102 |
| CAH | Cardinal Health Inc | 92,000 | $7.539M | 1.5% | $60.16 | +1.7% | COM | 14149Y108 |
| — | Aetna Inc | 67,000 | $7.527M | 1.5% | $104.69 | — | COM | 00817Y108 |
| ABBV | AbbVie Inc | 130,000 | $7.426M | 1.5% | $37.54 | -1.1% | COM | 00287Y109 |
| — | Endo International Plc | 260,000 | $7.319M | 1.5% | $48.55 | — | SHS | G30401106 |
| — | Express Scripts Hg Co | 106,000 | $7.281M | 1.4% | $81.84 | — | COM | 30219G108 |
| — | Nektar Therapeutics | 525,000 | $7.219M | 1.4% | $11.22 | — | COM | 640268108 |
| AMGN | Amgen Inc | 45,000 | $6.747M | 1.3% | $112.46 | -1.5% | COM | 031162100 |
| ELV | Anthem Inc | 47,000 | $6.533M | 1.3% | $134.01 | -13.0% | COM | 036752103 |
| MCK | McKesson Corp | 40,000 | $6.29M | 1.2% | $191.15 | -21.7% | COM | 58155Q103 |
| VRTX | Vertex Pharmaceuticals Inc | 78,000 | $6.2M | 1.2% | $102.25 | -11.5% | COM | 92532F100 |
| — | Cooper Companies Inc (The) | 40,000 | $6.159M | 1.2% | $171.80 | — | COM | 216648402 |
| COR | AmerisourceBergen Corp | 63,000 | $5.453M | 1.1% | $63.28 | +4.7% | COM | 03073E105 |
| DXCM | Dexcom Inc | 75,000 | $5.093M | 1.0% | $12.76 | +30.9% | COM | 252131107 |
| — | Cepheid Inc | 150,000 | $5.004M | 1.0% | $38.84 | — | COM | 15670R107 |
| HUM | Humana Inc | 27,000 | $4.94M | 1.0% | $170.02 | -5.8% | COM | 444859102 |
| EW | Edwards Lifesciences Corp | 55,000 | $4.852M | 1.0% | $20.87 | +32.2% | COM | 28176E108 |
| — | Cerner Corp | 86,000 | $4.555M | 0.9% | $61.66 | — | COM | 156782104 |
| — | Keryx Biopharmaceuticals Inc | 950,000 | $4.437M | 0.9% | $6.26 | — | COM | 492515101 |
| — | ZELTIQ Aesthetics Inc | 160,000 | $4.346M | 0.9% | $29.38 | — | COM | 98933Q108 |
| REGN | Regeneron Pharmaceuticals Inc | 12,000 | $4.325M | 0.9% | $378.17 | +8.4% | COM | 75886F107 |
| CYH | Community Health Syst Inc | 225,000 | $4.165M | 0.8% | $26.36 | -42.1% | COM | 203668108 |
| SUPN | Supernus Pharmaceuticals Inc | 270,000 | $4.118M | 0.8% | $8.32 | +56.7% | COM | 868459108 |
| HALO | Halozyme Therapeutics Inc | 431,000 | $4.082M | 0.8% | $16.27 | -42.2% | COM | 40637H109 |
| JAZZ | Jazz Pharmaceuticals Plc | 30,000 | $3.917M | 0.8% | $170.18 | -26.9% | SHS | G50871105 |
| — | Ariad Pharmaceuticals Inc | 600,000 | $3.834M | 0.8% | $6.68 | — | COM | 04033A100 |
| BDX | Becton Dickinson & Co | 25,000 | $3.796M | 0.8% | $118.02 | +3.5% | COM | 075887109 |
| LIVN | Livanova Plc | 70,000 | $3.779M | 0.8% | $60.40 | -8.0% | COM | G5509L101 |
| — | Endologix Inc | 435,000 | $3.637M | 0.7% | $12.10 | — | COM | 29266S106 |
| — | Horizon Pharma Plc | 200,000 | $3.314M | 0.7% | $20.29 | — | COM | G4617B105 |
| — | Radius Health Inc | 105,000 | $3.301M | 0.7% | $31.44 | — | COM | 750469207 |
| — | Intra-Cellular Therapies Inc | 115,000 | $3.197M | 0.6% | $19.23 | — | COM | 46116X101 |
| — | Heartware Intl Inc | 100,000 | $3.142M | 0.6% | $47.88 | — | COM | 422368100 |
| OMCL | Omnicell Inc | 110,000 | $3.066M | 0.6% | $31.17 | -11.9% | COM | 68213N109 |
| — | Lion Biotechnologies Inc | 600,000 | $3.048M | 0.6% | $8.39 | — | COM | 53619R102 |
| — | Cempra Inc | 171,000 | $2.996M | 0.6% | $33.87 | — | COM | 15130J109 |
| — | Revance Therapeutics Inc | 170,000 | $2.968M | 0.6% | $25.76 | — | COM | 761330109 |
| — | Dynavax Technologies Corp | 150,000 | $2.886M | 0.6% | $20.77 | — | COM | 268158201 |
| PODD | Insulet Corp | 82,000 | $2.719M | 0.5% | $34.93 | -10.1% | COM | 45784P101 |
| XNCR | Xencor Inc | 200,000 | $2.684M | 0.5% | $14.41 | -17.9% | COM | 98401F105 |
| EXEL | Exelixis Inc | 650,000 | $2.6M | 0.5% | $5.20 | -18.6% | COM | 30161Q104 |
| IONS | Ionis Pharmaceuticals Inc | 64,000 | $2.592M | 0.5% | $53.96 | -24.7% | COM | 462222100 |
| — | Chimerix Inc | 500,000 | $2.555M | 0.5% | $11.04 | — | COM | 16934W106 |
| ESPR | Esperion Therapeutics Inc | 150,000 | $2.537M | 0.5% | $20.34 | -20.9% | COM | 29664W105 |
| RARE | Ultragenyx Pharmaceutical Inc | 40,000 | $2.532M | 0.5% | $65.43 | 0.0% | COM | 90400D108 |
| — | FibroGen Inc | 114,000 | $2.427M | 0.5% | $25.32 | — | COM | 31572Q808 |
| NBIX | Neurocrine Biosciences Inc | 60,000 | $2.373M | 0.5% | $39.68 | 0.0% | COM | 64125C109 |
| MGNX | Macrogenics Inc | 120,000 | $2.25M | 0.4% | $25.43 | -25.1% | COM | 556099109 |
| — | Portola Pharmaceuticals Inc | 105,000 | $2.142M | 0.4% | $35.25 | — | COM | 737010108 |
| PCRX | Pacira Pharmaceuticals Inc | 40,000 | $2.119M | 0.4% | $56.86 | +2.9% | COM | 695127100 |
| HOLX | Hologic Inc | 60,000 | $2.07M | 0.4% | $29.00 | +20.3% | COM | 436440101 |
| — | Achillion Pharmaceuticals Inc | 266,000 | $2.054M | 0.4% | $9.71 | — | COM | 00448Q201 |
| — | Tandem Diabetes Care Inc | 209,000 | $1.82M | 0.4% | $12.69 | — | COM | 875372104 |
| — | Rigel Pharmaceuticals Inc | 850,000 | $1.768M | 0.4% | $3.57 | — | COM | 766559603 |
| — | Catabasis Pharmaceuticals Inc | 345,100 | $1.739M | 0.3% | $10.91 | — | COM | 14875P107 |
| — | Anthera Pharmaceuticals Inc | 435,000 | $1.575M | 0.3% | $3.60 | — | COM | 03674U201 |
| ACAD | Acadia Pharmaceuticals Inc | 50,000 | $1.398M | 0.3% | $25.97 | -15.9% | COM | 004225108 |
| — | Tetraphase Pharmaceuticals Inc | 300,000 | $1.389M | 0.3% | $17.20 | — | COM | 88165N105 |
| — | Regulus Therapeutic Inc | 200,000 | $1.386M | 0.3% | $6.54 | — | COM | 75915K101 |
| — | Valeant Pharm Intl Inc | 50,000 | $1.315M | 0.3% | $101.65 | — | COM | 91911K102 |
| — | Nevro Corp | 20,000 | $1.125M | 0.2% | $56.25 | — | COM | 64157F103 |
| — | Array BioPharma Inc | 370,000 | $1.092M | 0.2% | $4.79 | — | COM | 04269X105 |
| — | Mirati Therapeutics Inc | 50,000 | $1.07M | 0.2% | $31.48 | — | COM | 60468T105 |
| — | Avalanche Biotechnologies Inc | 154,006 | $796K | 0.2% | $23.02 | — | COM | 05337G107 |
| — | Orexigen Therapeutics Inc | 1,200,000 | $675K | 0.1% | $5.13 | — | COM | 686164104 |
| OCUL | Ocular Therapeutix Inc | 40,000 | $386K | 0.1% | $7.57 | 0.0% | COM | 67576A100 |
| — | BIND Therapeutics Inc | 133,535 | $294K | 0.1% | $11.18 | — | COM | 05548N107 |
| — | Threshold Pharmaceuticals | 201,537 | $93,000 | 0.0% | $4.08 | — | COM | 885807206 |